Abstract:Metal nanoparticles have been helpful
in creatinine sensing technology
under point-of-care (POC) settings because of their excellent electrocatalyst
properties. However, the behavior of monometallic nanoparticles as
electrochemical creatinine sensors showed limitations concerning the
current density in the mA/cm2 range and wide detection
window, which are essential parameters for the development of a sensor
for POC applications. Herein, we report a new sensor, a reduced graphene
oxide stabilized binary copper–… Show more
“…Singh et al developed a point-of-care device for detecting creatinine. 102 First, an electrode was made with 3D printing of conductive Ag ink on a flame retardant grade 1 (FR1) PCB substrate and using a Voltera V-One conductive ink printer. One electrode was then modified with electrodeposited rGO and then with electrodeposited Cu and Fe to form the sensor.…”
Section: Applications Of Creatinine Sensors In Point-of-care Devicesmentioning
Creatinine is an amino acid derived from creatine catabolism at different steps of the body's organs, and its detection is significant because levels out of normal values are linked to some diseases like kidney failure.
“…Singh et al developed a point-of-care device for detecting creatinine. 102 First, an electrode was made with 3D printing of conductive Ag ink on a flame retardant grade 1 (FR1) PCB substrate and using a Voltera V-One conductive ink printer. One electrode was then modified with electrodeposited rGO and then with electrodeposited Cu and Fe to form the sensor.…”
Section: Applications Of Creatinine Sensors In Point-of-care Devicesmentioning
Creatinine is an amino acid derived from creatine catabolism at different steps of the body's organs, and its detection is significant because levels out of normal values are linked to some diseases like kidney failure.
“…H 2 O 2 reacts with O 2 * – to produce again (*OH), ( − OH), and O 2 molecules. The *OH/ – OH thus initiates the creatinine auto-oxidation and produces oxime by removal of hydrogen. ,, (ii) The creatinine forms a complex with Cu 1+ through the co-ordination bond as shown in Scheme . As confirmed from the optimized FESEM images of the hybrid electrode (SnO 2 (6)@Cu 2 O), a large number of Cu 2 O NPs are available to bind with the creatinine molecule and form Cu(1)-complex.…”
Section: Resultsmentioning
confidence: 99%
“…Determination of creatinine level in blood serum or urine is clinically very important because it indicates renal dysfunction, muscle damage, thyroid disease, biomedical diagnosis of sever heart attack, and the quantitative measurement of hemodialysis therapy . The normal level of creatinine in blood serum lies in the range of ∼40–150 μM (0.46–1.7 mg/dL) . However, the amount greater than 500 μM indicates severe renal impairment that eventually leads to regular dialysis or kidney transplantation, which is of great concern worldwide.…”
Section: Introductionmentioning
confidence: 99%
“…Other well-established techniques, for example, voltammetric, spectroscopic, potentiometric, and chromatographic, have also been commonly employed for creatinine measurements . They also have several complications like a tedious sample preparation method, a requirement of sophisticated laboratory techniques, low sensitivity, interfering issues, and the lack of precise quantitative measurements, which restrict the use of the rapid onsite monitoring and point-of-care diagnosis . Sandeep Yadav et al prepared enzyme-based iron oxide composites (Fe 3 O 4 -NPs/CHIT-g-PANI) for creatinine detection and obtained a sensitivity of ∼3900 μA mM –1 cm –2 with 1 μM limit of detection (LOD) .…”
Section: Introductionmentioning
confidence: 99%
“… 3 The normal level of creatinine in blood serum lies in the range of ∼40–150 μM (0.46–1.7 mg/dL). 6 However, the amount greater than 500 μM indicates severe renal impairment that eventually leads to regular dialysis or kidney transplantation, which is of great concern worldwide. Patients suffering from kidney problems always need a portable device to check their creatinine level on a daily basis at home.…”
Advanced anodic SnO2 nanoporous structures
decorated
with Cu2O nanoparticles (NPs) were employed for creatinine
detection. Anodization of electropolished Sn sheets in 0.3 M aqueous
oxalic acid electrolyte under continuous stirring produced complete
open top, crack-free, and smooth SnO2 nanoporous structures.
Structural analyses confirm the high purity of rutile SnO2 with successful functionalization of Cu2O NPs. Morphological
studies revealed the formation of self-organized and highly-ordered
SnO2 nanopores, homogeneously decorated with Cu2O NPs. The average diameter of nanopores is ∼35 nm, while
the average Cu2O particle size is ∼23 nm. Density
functional theory results showed that SnO2@Cu2O hybrid nanostructures are energetically favorable for creatinine
detection. The hybrid nanostructure electrode exhibited an ultra-high
sensitivity of around 24343 μA mM–1 cm–2 with an extremely lower detection limit of ∼0.0023
μM, a fast response time (less than 2 s), and wide linear detection
ranges of 2.5–45 μM and 100 μM to 15 mM toward
creatinine. This is ascribed to the creation of highly active surface
sites as a result of Cu2O NP functionalization, SnO2 band gap diminution, and the formation of heterojunction
and Cu(1)/Cu(ll)–creatinine complexes through secondary amines
which occur in the creatinine structure. The real-time analysis of
creatinine in blood serum by the fabricated electrode evinces the
practicability and accuracy of the biosensor with reference to the
commercially existing creatinine sensor. The proposed biosensor demonstrated
excellent stability, reproducibility, and selectivity, which reflects
that the SnO2@Cu2O nanostructure is a promising
candidate for the non-enzymatic detection of creatinine.
Uric acid (UA) is a blood and urine component obtained as a metabolic by‐product of purine nucleotides. Abnormalities in UA metabolism cause crystal deposition as monosodium urate and lead to various diseases such as gout, hyperuricemia, Lesch–Nyhan syndrome, etc. Monitoring these diseases requires a rapid, sensitive, selective, and portable detection approach. Therefore, this study demonstrates the hydrothermal synthesis of CuFe2O4/reduced graphene oxide (rGO) nanocomposite for selective detection of UA. After the nanocomposite synthesis, characterization was performed by X‐ray diffraction spectroscopy, Fourier transform infrared spectroscopy, Raman spectroscopy, X‐ray photoelectron spectroscopy, UV–visible spectrometry, atomic force spectroscopy, scanning electron microscopy, and electrochemical analysis. Furthermore, from the electrochemical analysis using cyclic voltammetry (CV), kinetic studies were carried out by varying the scan rate to obtain the diffusion coefficient, surface concentration, and rate of charge transfer to achieve a calibration curve that indicates the quasi reversible nature of the fabricated electrode with a linear regression coefficient of oxidation (R2: 0.9992) and reduction (R2: 0.9971) peaks. Moreover, the fabricated nonenzymatic amperometric sensor to detect UA with a linearity (R2: 0.9989) of 1–400 μM was highly sensitive (2.75 × 10−4 mAμM−1 cm−2) and had a lower limit of detection (0.01231 μM) at pH 7.5 in phosphate‐buffered saline solution. Therefore, the CuFe2O4/rGO/ITO‐based nonenzymatic sensor could detect interfering agents and spiked real bovine serum samples with higher sensitivity and selectivity for UA detection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.